Anavex Life Sciences Corp.
Stock Forecast, Prediction & Price Target
Anavex Life Sciences Corp. Financial Estimates
Anavex Life Sciences Corp. Revenue Estimates
Anavex Life Sciences Corp. EBITDA Estimates
Anavex Life Sciences Corp. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 | 9/30/2027 | 9/30/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $14.37M Low: $11.91M High: $16.84M avg. 0% | Avg: $3.4M Low: $2.81M High: $3.98M avg. -76.35% | Avg: $49M Low: $40.58M High: $57.40M avg. 1341.17% | Avg: $4M Low: $3.31M High: $4.68M avg. -91.83% |
Net Income
% change YoY
| $-47.97M N/A | $-47.50M 0.98% | $-43.00M 9.47% | Avg: $-56.7M Low: $-63.83M High: $-38.29M avg. -31.85% | Avg: $-35.5M Low: $-37.07M High: $-23.55M avg. 37.38% | Avg: $-6.38M Low: $-7.80M High: $-4.95M avg. 82.01% | Avg: $-40.69M Low: $-49.76M High: $-31.61M avg. -537.50% |
EBITDA
% change YoY
| $-50.08M N/A | $-55.75M -11.32% | $0 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.62 N/A | -$0.6 3.22% | -$0.52 13.33% | Avg: -$0.64 Low: -$0.8 High: -$0.48 avg. -23.07% | Avg: -$0.38 Low: -$0.46 High: -$0.3 avg. 40.62% | Avg: -$0.08 Low: -$0.1 High: -$0.06 avg. 78.94% | Avg: -$0.51 Low: -$0.62 High: -$0.4 avg. -537.5% |
Operating Expenses
% change YoY
| $50.98M N/A | $55.75M 9.35% | $52.87M -5.16% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Anavex Life Sciences Corp. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -112.48% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -63.83M, average is -56.7M and high is -38.29M.
What is Anavex Life Sciences Corp. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 293.24% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $11.91M, average is $14.37M and high is $16.84M.
What is Anavex Life Sciences Corp. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -110.25% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.8, average is -$0.64 and high is $-0.48.